Uncategorized

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors

by Business Wire • 2017/10/02 • 0 Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals announced the appointment of Andrew I. Koven to the Company’s Board of Directors.

← Presbia to Participate in the XXXV Congress of the European Society of Cataract & Refractive Surgeons and in the International Society of Presbyopia 2017

German Ophthalmological Society (DOG) Honors Uta Gehlsen, PhD, with Prestigious Scientific Award for Her Research on the Use of Semifluorinated Alkanes in Dry Eye Treatment →